Crossmark

Repurposing drugs against Alzheimer’s disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?

Crossref DOI link: https://doi.org/10.1007/s00702-023-02618-5

Published Online: 2023-04-04

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leßmann, Volkmar https://orcid.org/0000-0002-6863-323X
Kartalou, Georgia-Ioanna

Endres, Thomas

Pawlitzki, Marc

Gottmann, Kurt
Funding

Funding for this research was provided by:

EU Joint Programme – Neurodegenerative Disease Research (643417 CIRCPROT)

Deutsche Forschungsgemeinschaft (GRK 2413)

DFG (CRC 1436 TP A06)

Otto-von-Guericke-Universität Magdeburg
License Information

Text and Data Mining valid from 2023-04-04

Version of Record valid from 2023-04-04
More Information

Article History

Received: 6 November 2022

Accepted: 2 March 2023

First Online: 4 April 2023

Document is current

Any future updates will be listed below